Back

Revisiting the Definition of Acral Melanoma: Unraveling Histology and Location

Beagles, E.; Khattab, S.; Burke, O. M.; Mahajan, A.; Ciampa, D.; Xu, S.; Thang, C.; Moseley, C.; Wan, G.; Chang, C.; Lu, C.; Nguyen, N.; Hartman, R. I.; Asgari, M. M.; DeSimone, M.; Hurlbert, M. S.; Semenov, Y.

2025-06-25 dermatology
10.1101/2025.06.24.25330235 medRxiv
Show abstract

Acral melanoma (AM) is a rare subtype of melanoma associated with poor prognosis. However, inconsistent definitions--based on either anatomic location (e.g., palms, soles, subungual areas) or histopathologic subtype (e.g., acral lentiginous melanoma)--complicate prognostication, hinder treatment decision-making, and pose challenges for both clinical and translational research. This multi-institutional retrospective cohort study aimed to determine whether anatomic location or histologic subtype better predicts outcomes in AM. Distal extremity primary melanomas (n = 469) were matched 1:2 with cutaneous melanomas (CMs; n = 938). Cox proportional hazards models evaluated recurrence-free survival (RFS), melanoma-specific survival (MSS), and overall survival (OS). Of the distal tumors, 280 (59.7%) were ALMs, including 33 (11.8%) on non-subungual dorsal sites. Compared to CMs, acral surface melanomas had worse outcomes, while dorsal melanomas had similar outcomes, independent of histology. ALMs were associated with worse survival than superficial spreading melanomas (SSMs). In interaction models, ALMs on dorsal surfaces and all histologic subtypes on acral surfaces had worse MSS than non-distal SSMs. A revised definition of AM may better inform clinical management and future research.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Experimental Dermatology
10 papers in training set
Top 0.1%
14.8%
2
European Journal of Cancer
10 papers in training set
Top 0.1%
10.4%
3
PLOS Medicine
98 papers in training set
Top 0.2%
8.6%
4
Frontiers in Medicine
113 papers in training set
Top 0.6%
6.5%
5
Journal of Investigative Dermatology
42 papers in training set
Top 0.1%
6.5%
6
BMC Cancer
52 papers in training set
Top 0.3%
5.0%
50% of probability mass above
7
PLOS ONE
4510 papers in training set
Top 34%
4.3%
8
JAMA Network Open
127 papers in training set
Top 0.8%
3.8%
9
Scientific Reports
3102 papers in training set
Top 34%
3.7%
10
eClinicalMedicine
55 papers in training set
Top 0.2%
2.4%
11
Cancers
200 papers in training set
Top 2%
2.2%
12
JCI Insight
241 papers in training set
Top 3%
1.9%
13
Frontiers in Immunology
586 papers in training set
Top 3%
1.9%
14
eLife
5422 papers in training set
Top 37%
1.9%
15
Blood Advances
54 papers in training set
Top 0.6%
1.9%
16
Nature Communications
4913 papers in training set
Top 49%
1.8%
17
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.3%
1.7%
18
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.4%
1.3%
19
British Journal of Cancer
42 papers in training set
Top 1%
1.3%
20
Experimental Eye Research
30 papers in training set
Top 0.4%
1.3%
21
Metabolites
50 papers in training set
Top 0.7%
1.1%
22
OncoImmunology
22 papers in training set
Top 0.3%
1.1%
23
Journal of Clinical Pathology
12 papers in training set
Top 0.3%
1.1%
24
Human Genomics
21 papers in training set
Top 0.2%
0.9%
25
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 0.9%
0.9%
26
Frontiers in Public Health
140 papers in training set
Top 7%
0.8%
27
Journal of Advanced Research
15 papers in training set
Top 0.7%
0.8%
28
Cureus
67 papers in training set
Top 6%
0.7%
29
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.2%
0.5%